Prosecution Insights
Last updated: October 02, 2026
Application No. 18/475,520

ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE

Non-Final OA §112
Filed
Sep 27, 2023
Priority
Jan 31, 2023 — RE 10-2023-0013182
Examiner
WARD, PAUL V
Art Unit
1622
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Samsung Display Co., Ltd.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
71%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1417 granted / 1704 resolved
+23.2% vs TC avg
Minimal -12% lift
Without
With
+-12.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
59 currently pending
Career history
1729
Total Applications
across all art units

Statute-Specific Performance

§101
5.4%
-34.6% vs TC avg
§103
20.4%
-19.6% vs TC avg
§102
18.8%
-21.2% vs TC avg
§112
42.3%
+2.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1704 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION STATUS OF THE CLAIMS: Claims 1-20 are pending in this application. Election/Restrictions Applicants’ election of species in the reply filed on February 22, 2026, is acknowledged. All claims were examined. Claim Objections Claim 20 is objected to because of the following informalities: the claims does not end with a period (“.”). Appropriate correction is required. Claim Rejections - 35 USC § 112, first paragraph The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-20 (including claims dependent thereon and claims that relate back to or refer to independent claim 1) are rejected under 35 U.S.C. 112, first paragraph, because the specification, while being enabling for some of the R groups listed within the specification of the current application, does not reasonably provide enablement for all of the PTM groups listed within the application. The specification does not enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make the invention commensurate in scope with these claims. The test of enablement is whether one skilled in the art could make and use the claimed invention from the disclosures in the application coupled with information known in the art without undue experimentation. (United States v. Teletronics Inc., 8 USPQ2d 1217 (Fed. Cir. 1988)). Whether undue experimentation is needed is not based on a single factor, but rather a conclusion reached by weighing many factors (See Ex parte Forman 230 USPX 546 (BD. Pat. App. & Inter. 1986) and In re Wands, 8 USPQ2d 1400 (Fed. Cir. 1988). 1. Amount of guidance provided by Applicant. While the Applicant has demonstrated within the application a select number of the organometallic compounds, the generic claims according to formula I are massive, and only a small fraction of these compounds are disclosed, discussed, and their synthesis shown. In the claims and specification, applicants claim various variables for CY, L and R variables, which includes for C6-C60carbocyclic groups, C1-C60 heterocyclic groups as well as various “R” groups that are aryl, heteroaryl, and heterocyclo, carbocyclic, D, H, halogens, hydroxyl, cyano, nitro and etc. groups. However, the specification fails to teach all of these compounds, nor does the specification define the ring size, heteroatom, number and nature of substituents, and the exact point of contact with the atom(s) for the substituents. 2. Unpredictability in the art. It is well established that “the scope of enablement varies inversely with the degree of unpredictability of the factors involved”, and physiological activity is generally considered to be an unpredictable factor. (USPQ 18, 24 (CCPA 1970). See In re Fisher, 427 F.2d 833, 839, 166. 3. Number of working examples. Applicants have provided working examples of the compounds (i.e., where CY, L and R variables are defined); however, these examples only read on a minute portion of the massive claims according to general formula I in the present application. 4. Scope of the claims. The scope, of the claims, involves a plethora of compounds of general formula I: PNG media_image1.png 412 542 media_image1.png Greyscale wherein all the variables are defined in the claim. For example, in defining CY, L and R variables: PNG media_image2.png 212 782 media_image2.png Greyscale PNG media_image3.png 642 786 media_image3.png Greyscale Thus, the scope of the claims is very broad. 5. Nature of the invention. The nature of this invention relates generally organometallic compounds used in light-emitting devices and electronic apparatus. 6. Level of skill in the art. The artisan using Applicant’s invention would be a chemist with a Ph.D. degree and having several years of bench experience. MPEP § 2164.01 (1) states, “A conclusion of lack of enablement means that, based on the evidence regarding each of the above factors, the specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full scope of the claimed invention without undue experimentation. In re Wright, 999 F.2d. 1557, 1562, 27 USPQ2d 1510, 1513 (Fed. Cir. 1993).” Thus, this conclusion is clearly justified here. Therefore, Applicant is not enabled for all of these compounds or compositions. Conclusion Claims 1-20 are pending. Claims 1-20 are rejected. No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAUL V WARD whose telephone number is (571)272-2909. The examiner can normally be reached M-F 9am to 5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Alstrum-Acevedo can be reached at 571-272-5548. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PAUL V WARD/Primary Examiner, Art Unit 1622
Read full office action

Prosecution Timeline

Sep 27, 2023
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747205
SULFUR-CONTAINING LIPIDS
3y 2m to grant Granted Sep 29, 2026
Patent 12734277
CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT
4y 4m to grant Granted Sep 15, 2026
Patent 12714718
TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL
3y 11m to grant Granted Aug 25, 2026
Patent 12714659
COSMETIC
3y 5m to grant Granted Aug 25, 2026
Patent 12708609
METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
2y 9m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
71%
With Interview (-12.2%)
2y 4m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1704 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month